258 related articles for article (PubMed ID: 9006556)
21. Time Is of the Essence: The Impact of Delayed Antibiotic Therapy on Patient Outcomes in Hospital-Onset Enterococcal Bloodstream Infections.
Zasowski EJ; Claeys KC; Lagnf AM; Davis SL; Rybak MJ
Clin Infect Dis; 2016 May; 62(10):1242-1250. PubMed ID: 26945013
[TBL] [Abstract][Full Text] [Related]
22. Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.
Bae KS; Shin JA; Kim SK; Han SB; Lee JW; Lee DG; Chung NG; Cho B; Jeong DC; Kang JH
Infection; 2019 Jun; 47(3):417-424. PubMed ID: 30565009
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for mortality associated with enterococcal bloodstream infections.
Stroud L; Edwards J; Danzing L; Culver D; Gaynes R
Infect Control Hosp Epidemiol; 1996 Sep; 17(9):576-80. PubMed ID: 8880229
[TBL] [Abstract][Full Text] [Related]
24. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance.
Remschmidt C; Schröder C; Behnke M; Gastmeier P; Geffers C; Kramer TS
Antimicrob Resist Infect Control; 2018; 7():54. PubMed ID: 29760912
[TBL] [Abstract][Full Text] [Related]
25. Mortality in enterococcal bloodstream infections increases with inappropriate antimicrobial therapy.
Suppli M; Aabenhus R; Harboe ZB; Andersen LP; Tvede M; Jensen JU
Clin Microbiol Infect; 2011 Jul; 17(7):1078-83. PubMed ID: 20946408
[TBL] [Abstract][Full Text] [Related]
26. Bloodstream infections with vancomycin-resistant enterococci.
Montecalvo MA; Shay DK; Patel P; Tacsa L; Maloney SA; Jarvis WR; Wormser GP
Arch Intern Med; 1996 Jul; 156(13):1458-62. PubMed ID: 8678715
[TBL] [Abstract][Full Text] [Related]
27. E. faecalis vancomycin-sensitive enterococcal bacteremia unresponsive to a vancomycin tolerant strain successfully treated with high-dose daptomycin.
Cunha BA; Mickail N; Eisenstein L
Heart Lung; 2007; 36(6):456-61. PubMed ID: 18005808
[TBL] [Abstract][Full Text] [Related]
28. Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection.
DiazGranados CA; Jernigan JA
J Infect Dis; 2005 Feb; 191(4):588-95. PubMed ID: 15655783
[TBL] [Abstract][Full Text] [Related]
29. Enterococcal bacteremia in a medical center.
Peng MY; Young TG; Yang CH; Chou MY
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Nov; 54(5):306-11. PubMed ID: 7834553
[TBL] [Abstract][Full Text] [Related]
30. Enterococcal bacteremia in a teaching hospital in the Central region of Saudi Arabia.
Al-Otaibi FE; Kambal AM; Baabbad RA
Saudi Med J; 2004 Jan; 25(1):21-5. PubMed ID: 14758373
[TBL] [Abstract][Full Text] [Related]
31. Infectious Diseases Consultation Improves Treatment and Decreases Mortality by Enterococcal Bacteremia in Children.
Furuichi M; Furuichi M; Horikoshi Y; Miyairi I
Pediatr Infect Dis J; 2018 Sep; 37(9):856-860. PubMed ID: 29384980
[TBL] [Abstract][Full Text] [Related]
32. Enterococcal bacteremia is associated with increased risk of mortality in recipients of allogeneic hematopoietic stem cell transplantation.
Vydra J; Shanley RM; George I; Ustun C; Smith AR; Weisdorf DJ; Young JA
Clin Infect Dis; 2012 Sep; 55(6):764-70. PubMed ID: 22693346
[TBL] [Abstract][Full Text] [Related]
33. Vancomycin resistance and mortality associated with enterococcal bacteremia.
Lautenbach E; Brennan PJ
Clin Infect Dis; 1997 Mar; 24(3):530-1. PubMed ID: 9114224
[No Abstract] [Full Text] [Related]
34. [Therapeutic impact of streptococcal and enterococcal bacteremia in hematology patients].
Ombandza-Moussa E; Schlegel L; Vekhoff A; Gerbal R; Marie JP; Bouvet A
Pathol Biol (Paris); 2002 Apr; 50(3):169-77. PubMed ID: 11980330
[TBL] [Abstract][Full Text] [Related]
35. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality.
Papanicolaou GA; Meyers BR; Meyers J; Mendelson MH; Lou W; Emre S; Sheiner P; Miller C
Clin Infect Dis; 1996 Oct; 23(4):760-6. PubMed ID: 8909841
[TBL] [Abstract][Full Text] [Related]
36. Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.
Ghanem G; Hachem R; Jiang Y; Chemaly RF; Raad I
Infect Control Hosp Epidemiol; 2007 Sep; 28(9):1054-9. PubMed ID: 17932826
[TBL] [Abstract][Full Text] [Related]
37. Enterococcal endocarditis on native and prosthetic valves: a review of clinical and prognostic factors with emphasis on hospital-acquired infections as a major determinant of outcome.
Fernández Guerrero ML; Goyenechea A; Verdejo C; Roblas RF; de Górgolas M
Medicine (Baltimore); 2007 Nov; 86(6):363-377. PubMed ID: 18004181
[TBL] [Abstract][Full Text] [Related]
38. Australian Enterococcal Sepsis Outcome Programme annual report, 2013.
Coombs GW; Pearson JC; Daly DA; Le TT; Robinson JO; Gottlieb T; Howden BP; Johnson PD; Bennett CM; Stinear TP; Turnidge JD;
Commun Dis Intell Q Rep; 2014 Dec; 38(4):E320-6. PubMed ID: 25631594
[TBL] [Abstract][Full Text] [Related]
39. Clinical features of enterococcal bacteremia due to ampicillin-susceptible and ampicillin-resistant enterococci: An eight-year retrospective comparison study.
Hamada Y; Magarifuchi H; Oho M; Kusaba K; Nagasawa Z; Fukuoka M; Yamakuchi H; Urakami T; Aoki Y
J Infect Chemother; 2015 Jul; 21(7):527-30. PubMed ID: 25935477
[TBL] [Abstract][Full Text] [Related]
40. Vancomycin-resistant-enterococci--colonization of 24 patients on a pediatric oncology unit.
Schuster F; Graubner UB; Schmid I; Weiss M; Belohradsky BH
Klin Padiatr; 1998; 210(4):261-3. PubMed ID: 9743963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
